SOURCE: Edwards Lifesciences

Edwards Lifesciences

September 04, 2009 13:45 ET

Edwards Lifesciences to Present at the UBS Fourth Annual Best of Americas Conference

IRVINE, CA--(Marketwire - September 4, 2009) - Edwards Lifesciences Corporation (NYSE: EW), a world leader in products and technologies to treat advanced cardiovascular disease, is scheduled to participate in the UBS Fourth Annual Best of Americas Conference at UBS' offices in London, England on Friday, September 11, 2009.

Patrick B. Verguet, Edwards Lifesciences' corporate vice president, Europe, is scheduled to speak to conference attendees at 10:00 a.m. British Summer Time. A live webcast of the presentation will be available to all interested parties on the Edwards Lifesciences investor relations website at http://www.edwards.com/InvestorRelations/EventCalendar.htm. An archived version of the webcast will be available later that day on the Edwards investor relations website in the News and Events section.

About Edwards Lifesciences

Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring, with more than five decades of experience in partnering with clinicians to develop life-saving innovations. Headquartered in Irvine, Calif., Edwards treats advanced cardiovascular disease with its market-leading heart valve therapies, and critical care and vascular technologies, which are sold in approximately 100 countries. The company's global brands include Carpentier-Edwards, Cosgrove-Edwards, Edwards SAPIEN, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional company information can be found at http://www.edwards.com.

Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences, the stylized E logo, Carpentier-Edwards, Cosgrove-Edwards, Edwards SAPIEN, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.

Contact Information

  • Media Contact:
    Amanda Fowler
    949-250-5070

    Investor Contact:
    David K. Erickson
    949-250-6826